Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Cardiovascular Research|January 25, 2005
Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-betaJennifer Martin, Darren J Kelly, Sally A Mifsud, et al.
Nephrology (Carlton, Vic.)|March 5, 2004
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockadeDarren J Kelly, Alicia Stein-Oakley, Yuan Zhang, et al.
Acta Diabetologica|June 14, 2014
Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studiesKim A Connelly, Andrew Advani, Suzanne L Advani, et al.
Circulation Research|July 5, 2003
Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophyAlex Tzanidis, Ross D Hannan, Walter G Thomas, et al.
Plos One|December 7, 2013
Obesity is associated with lower coronary microvascular densityDuncan J Campbell, Jithendra B Somaratne, David L Prior, et al.
Circulation. Heart Failure|October 8, 2009
Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathyKim A Connelly, Darren J Kelly, Yuan Zhang, et al.
Plos One|October 17, 2012
A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the ratRichard E Gilbert, Yuan Zhang, Spencer J Williams, et al.
The American Journal of Pathology|January 1, 2003
The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studiesChristina J Moravski, Sandford L Skinner, Anthony J Stubbs, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2014
Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathyBrooke M Huuskes, Andrea F Wise, Alison J Cox, et al.
The American Journal of Pathology|March 25, 2004
Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathyJennifer L Wilkinson-Berka, Sanja Babic, Tanyth De Gooyer, et al.
Pageof 15